human PGAM2 shRNA silencing AAV
This is an AAV expressing shRNA for silencing of Human PGAM2.
shAAV-218719
AAV-h-PGAM2-shRNA
Ready-to-use AAV expressing shRNA for silencing of Human PGAM2 (phosphoglycerate mutase 2). Available with optional GFP reporter or cell-specific promoter.
Gene Reference Data
Alternate Names
GSD10; PGAM-M; PGAMM
Description (Vector)
Phosphoglycerate mutase (PGAM) catalyzes the reversible reaction of 3-phosphoglycerate (3-PGA) to 2-phosphoglycerate (2-PGA) in the glycolytic pathway. The PGAM is a dimeric enzyme containing, in different tissues, different proportions of a slow-migrating muscle (MM) isozyme, a fast-migrating brain (BB) isozyme, and a hybrid form (MB). This gene encodes muscle-specific PGAM subunit. Mutations in this gene cause muscle phosphoglycerate mutase eficiency, also known as glycogen storage disease X.
Gene ID
5224
Gene Name (Vector)
phosphoglycerate mutase 2
Gene Symbol
PGAM2
HGNC ID
HGNC:8889
ORF Size (aa)
762
RefSeq ID
NM_000290
RefSeq Synonyms
NM_000290, BC073741, BC001904,
Species
human
UniGene ID
Hs.632642
About Storage Conditions
All our viral products should be kept at -80°C. At this temperature, the virus will remain stable for 6-12 months (and in some cases, up to 2 years). Once thawed, the product can be stored at 4°C for 2-3 weeks without significant loss of biological activity.
We recommend aliquoting your vectors into low protein binding tubes upon receipt. This helps avoid repeated freeze-thaw cycles, as well as prevent loss of virus. To maintain accurate titer, aliquot in at least 20ul per tube.
